Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.
For many international patients seeking advanced medical care in Japan, a key logistical question is, “Can I travel back home immediately after my treatment?” This is a particularly common concern for those undergoing NK cell therapy, a treatment known for placing a relatively light burden on the body. While the procedure itself is straightforward, planning for a safe and comfortable return journey is an essential part of your care.
The general answer is that while the infusion process is not physically demanding, traveling on the same day is typically not recommended. A physician’s assessment is necessary to determine when you can travel safely. For many, flying the following day may be possible, but this decision must be based on your individual condition and response to the therapy.
Understanding the NK Cell Therapy Process
NK (Natural Killer) cell therapy is a form of immunotherapy that utilizes your own immune cells. The treatment begins with a simple blood draw. From this sample, your NK cells are isolated, then activated and expanded in number at a specialized cell processing facility. These enhanced cells are subsequently returned to your body via an intravenous (IV) infusion, a process similar to receiving a standard IV drip.
Because the therapy uses your own (autologous) cells, the risk of severe adverse reactions is generally considered low. The entire procedure is performed on an outpatient basis, meaning a hospital stay is not typically required. This allows patients to continue with many of their daily activities during the treatment course.
Why Post-Infusion Rest Is Important
The primary reason for advising against same-day travel is to allow for a period of rest and observation. While serious side effects have been reported infrequently, it is important to monitor your body’s initial response to the infusion.
- Observation Period: After the infusion, our clinic staff will monitor you for a short period to ensure you are feeling well.
- Potential Immune Response: Some individuals may experience temporary, mild symptoms such as a low-grade fever or fatigue. These are often signs that the infused NK cells are active and the immune system is responding. These symptoms usually resolve on their own within a short time.
- Benefits of Rest: Allowing your body to rest for the remainder of the day helps it recover and adjust. This is particularly important before undertaking a potentially stressful activity like a long-haul flight.
Factors Your Doctor Considers for Travel Clearance
The decision on when you can safely fly is a medical judgment that must be made by your treating physician. It is not a one-size-fits-all recommendation. Your doctor will evaluate several key factors to provide personalized advice:
- Your Overall Health: Your general physical condition, any pre-existing medical conditions, and your overall stamina are crucial considerations.
- Your Response to the Infusion: How you feel in the hours following the treatment is a primary indicator. The presence or absence of fever, fatigue, or other symptoms will inform the doctor’s recommendation.
- Flight Details: The duration of your flight is a significant factor. Long-haul flights can be physically taxing due to prolonged sitting, lower cabin pressure, and dry air.
- Your Complete Treatment Plan: If your treatment involves multiple infusions, your travel plans will need to be coordinated with your overall schedule.
Tips for a Safe and Comfortable Return Journey
Once your physician has cleared you for travel, taking a few precautions can help ensure your journey is as smooth and comfortable as possible.
- Stay Hydrated: Drink plenty of water before and during the flight to avoid dehydration.
- Move Around: On longer flights, it’s advisable to get up, stretch, and walk in the aisle periodically, when it is safe to do so. This helps promote blood circulation and can reduce the risk of deep vein thrombosis (DVT), a concern for any long-distance traveler, particularly those with underlying health conditions.
- Listen to Your Body: Avoid rushing or lifting heavy luggage. Don’t hesitate to request assistance at the airport if you feel you need it.
- Carry Medical Information: Keep the contact details of our clinic and a brief summary of your treatment with you.
Understanding NK Cell Therapy in Japan
For international patients, it is important to know that NK cell therapy is provided as a non-insured medical service (private practice). In Japan, this type of treatment is regulated under the Act on the Safety of Regenerative Medicine, which ensures that cell processing and medical care are provided based on plans reviewed and accepted by the Ministry of Health, Labour and Welfare.
The suitability of this therapy, the specific treatment plan, potential outcomes, risks, and side effects are different for every individual. Therefore, a comprehensive medical consultation with a physician is essential to determine if this is an appropriate option for you. All details, including treatment duration and costs, will be thoroughly explained during your consultation.
Plan Your Medical Journey with Us in Osaka
At Grand Green Osaka Umekita Clinic, we are committed to supporting our international patients throughout their medical journey. We strongly encourage you to discuss your travel plans with our medical team from the very beginning. This allows us to help coordinate a treatment schedule that prioritizes your health and allows for a safe return home.
To better understand the features and flow of our NK cell therapy, we invite you to review our detailed information page. Being well-informed will help you prepare for your consultation. For more information, please visit our NK Cell Therapy page.
In conclusion, your well-being is our highest priority. While NK cell therapy involves a straightforward infusion process, the decision about when to travel is a medical one that requires professional guidance. By planning ahead and maintaining open communication with your medical team, you can ensure a safe and well-managed conclusion to your treatment in Japan.
References
- PubMed: Efficacy and safety of first-line maintenance therapy with lurbinectedin plus atezolizumab in extensive-stage small-cell lung cancer (IMforte): a randomised, multicentre, open-label, phase 3 trial. (2025)
- PubMed: Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial. (2022)
- PubMed: Epcoritamab in relapsed/refractory large B-cell lymphoma: 2-year follow-up from the pivotal EPCORE NHL-1 trial. (2024)
- PubMed: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors. (2024)
- PubMed: Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: updated recommendations by the EBMT/ELN International Working Group. (2024)
- PMC: Autologous stem cell transplant recipients tolerate haploidentical related-donor natural killer cell-enriched infusions. (2013)
- PMC: Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial. (2025)
- PMC: Phase I study of intraventricular infusions of autologous ex vivo expanded NK cells in children with recurrent medulloblastoma and ependymoma. (2020)
- MHLW (Japan): Regenerative Medicine — Ministry of Health, Labour and Welfare, Japan
Supervising Physician
Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic
Hidenori Shimada
Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.
* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.